Welcome to this private area where members of the Investment Opportunities Newsletter can learn more about the latest portfolio company updates and investment news.
The table below provides a short summary and update for each portfolio company. If you would like to discuss any of the available opportunities, please get in touch with the listed contact.
Company | Company information | Status | Contact |
---|---|---|---|
Audiotelligence | Spin-out from Cedar Audio. Have developed noise-reduction software which can be embedded into a wide range of hardware, to clean and clarify the audio source, even in a very noisy background. | Update: Continues to expand customer base and application of its noise-reduction technology. | Elaine Loukes |
Cambris Cardiac | Next generation polymeric heart valves that last longer and do not require long term anticoagulant usage. | Completed: Pre-seed completed Aug 2021. Now raising a seed round. | Amanda Wooding |
Carbon Re | AI platform using deep reinforcement Learning to decarbonise energy intensive industries like cement. | Completed: Closed £1M pre-seed round Oct 2021 | Chris Gibbs |
Centessa Pharmaceuticals | Centessa Pharmaceuticals is an asset centric pharmaceutical company consisting of 10 subsidiary companies advancing a portfolio of programs with strong biological validation. These include Apcintex, Morphogen-IX and Z Factor. | Update: Centessa floated on the Nasdaq in June 2021. | Christine Martin |
Colorifix | Producing engineered microorganisms to produce pigments for dyeing of textiles with significantly reduced environmental impact. | Seeking investors: Colorfix is seeking investors to join a Series B. | Fatima Kranc |
Diagnostics for the Real World | Development of rapid simple cost effective and high performance diagnostic tests for resource-limited settings in both the developing and developed world. | Update: SAMBA technology has been deployed to provide a critical quick turn around COVID diagnostic. | Anne Dobree |
DIOSynVax | The DIOSynVax pipeline includes a broad-spectrum COV-2 DNA vaccine, a broad-spectrum Flu vaccine candidate, as well as an Ebola/Haemorrhagic fever vaccine. | Seeking Investors: DIOS is seeking investors for a Series A. | Terry Parlett |
Echion Technologies | Echion Technologies is developing a portfolio of advanced battery active anode materials for Li-ion batteries. | Completed: £10M Series A round in Sept 2021. | Chris Gibbs |
Healthera | Software platform designed to help patients manage their medication and get the most out of their local pharmacy and GP surgery. | Seeking Investors: Looking to raise a Growth Round of £3m-£4m in Q1 '22 off the back of significant ARR. Interested in talking to investors with the ability to lead this round of funding. | James Thomas |
iKVA (formerly Kvasir Analytics) | Semantic search technology that allows for a document to be used as a query (as opposed to keyword searching). | Update: Recently launched a start-up mapping tool for use by VC firms. | James Thomas |
Kalium Health | Kalium Health are transforming kidney and heart disease management through personal electrolyte monitoring with a fingerprick blood test for potassium. Device development is progressing well with an inital clinical accuracy study starting shortly. | Seeking Investors: Kalium Health are now actively seeking investors to participate in a Series A round. | Amanda Wooding |
NoBACZ Healthcare | NoBACZ Healthcare's Precision Bandaging platform will produce a wide range of rapid setting, liquid, biodegradable antimicrobial bandages for veterinary and human wound care. | Seeking Investors: NoBACZ will be seeking investors to participate at a Series A during 2022. | Amanda Wooding |
Pharmenable | Pharmenable use advanced medicinal chemistry and AI-enabled approaches to design the next generation of hit compounds for drug discovery. | Update: Pharmenable are speaking with investors with a view to raising their next funding round in late 2021/early 2022. | Christine Martin |
Psyomics | Psyomics is delivering better outcomes in mental health through a digital diagnostic which puts control into the hands of those seeking help and advice. | Update: Psyomics appointed accomplished digital mental health leader, Stephanie Martlew as CEO. | Anne Dobree |
Qkine | Qkine is a specialist manufacturer of proteins used in the fast-growing market of stem cell growth and differentiation. | Update: Qkine is focussing on launching new products and expanding its customer base through 2021. | Christine Martin |
RoboK Limited | Computer vision-based perception software for autonomous vehicles and other transport solutions. | Seeking Investors: Looking to begin raising a £3m round of investment in Q1 '22 to help accelerate existing commercial traction. Would welcome conversations with interested investors with the ability to lead the round. | James Thomas |
Sano Genetics | Online platform for patient recruitment for research into personalised medicine, that provides genome sequencing and analysis for research participants who retain ownership and control over their own data. | Seeking Investors: Currently raising a Series A round to capitalise on accelerating growth in revenue. Would be interested in speaking to investors who could participate in this round, especially potential leads. | James Thomas |
Semarion | Semarion has developed a novel class of materials for adherant cell manipulation. | Update: Semarion has benefitted from being a member of the Start Codon accelerator and is now raising a seed round. | Fatima Kranc |
Signaloid | Signaloid is a new startup from the work of Phillip Stanley-Marbell in Electrical Engineering that senses and computes on uncertain data to enable robust and trustworthy machine intelligence, autonomous systems and quantum computing. The Signaloid technology helps both human and machine decision makers understand their data better and take more confident actions. | Completed: £155k pre-seed round in July 2021 | Chris Gibbs |
Sorex Sensors | Ultrasensitive mass sensors for indoor air quality measurement. | Update: Currently fund raising. | Elaine Loukes |
Spirea | Novel antibody-drug-conjugate (ADC) linker technology to achieve higher drug-antibody-ratios (DAR). | Update: Spirea are currently pitching to investors for a seed raise. | Christine Martin |
Super-Sharp Space Systems (S4) | Self-aligning and unfolding primary for earth-observation/astronomy research via space-based high angular resolution photography. | Update: Currently fund raising. | Elaine Loukes |
Tenyks | Explainable AI technology for the testing, validation and maintenance of AI-based computer vision technologies (e.g. medical imaging). | Completed: Recently completed their Seed Round and were part of Y Combinator's S21 cohort. | James Thomas |
Versed AI | Natural Language Process software for the automated mapping of supply chain data. | Completed: Closed their Seed Round in May 2021. | James Thomas |
Xampla | Has developed a technique to make a range of materials from plant-proteins, allowing single-use plastics to be replaced with natural, biodegradable products. | Update: In June 2021 the Knowles Lab published a paper in Nature Communications describing how they create a polymer film from plant protein that is sustainable, scalable and 100 percent natural. | Elaine Loukes |
Zetta Genomics | Next generation storage of genomic information. | Completed: Seed Round financing. | Elaine Loukes |